Retinal pigment epithelium cells produce VEGF in response to oxidized phospholipids through mechanisms involving ATF4 and protein kinase CK2

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 177-184

  Pollreisz, Andreas ^a   Afonyushkin, Taras ^a   Oskolkova, Olga V ^a   Gruber, Florian ^b   Bochkov, Valery N ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Angiogenesis; Oxidized phospholipids; Protein kinase CK2; RPE; Unfolded protein response

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CASEIN KINASE II; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RETINA MACULA AGE RELATED DEGENERATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; UNFOLDED PROTEIN RESPONSE;

ANGIOGENESIS; OXIDIZED PHOSPHOLIPIDS; PROTEIN KINASE CK2; RPE; UNFOLDED PROTEIN RESPONSE;

ACTIVATING TRANSCRIPTION FACTOR 4; BLOTTING, WESTERN; CASEIN KINASE II; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MACULAR DEGENERATION; MASS SPECTROMETRY; OXIDATION-REDUCTION; PHOSPHOLIPIDS; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884725047     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.08.021     Document Type: Article

References (32)

1. Adamis A.P., Shima D.T., Yeo K.T., Yeo T.K., Brown L.F., Berse B., D'Amore P.A., Folkman J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Comm. 1993, 193:631-638.
2. Afonyushkin T., Oskolkova O.V., Binder B.R., Bochkov V.N. Involvement of CK2 in activation of electrophilic genes in endothelial cells by oxidized phospholipids. J.Lipid Res. 2011, 52:98-103.
3. Afonyushkin T., Oskolkova O.V., Philippova M., Resink T.J., Erne P., Binder B.R., Bochkov V.N. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1007-1013.
4. Ahmed K., Gerber D.A., Cochet C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 2002, 12:226-230.
5. Becerra S.P., Fariss R.N., Wu Y.Q., Montuenga L.M., Wong P., Pfeffer B.A. Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. Exp. Eye Res. 2004, 78:223-234.
6. Blaauwgeers H.G., Holtkamp G.M., Rutten H., Witmer A.N., Koolwijk P., Partanen T.A., Alitalo K., Kroon M.E., Kijlstra A., van Hinsbergh V.W., Schlingemann R.O. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am. J. Pathol. 1999, 155:421-428.
7. Bochkov V.N., Oskolkova O.V., Birukov K.G., Levonen A.L., Binder C.J., Stockl J. Generation and biological activities of oxidized phospholipids. Antiox. Redox Sign. 2010, 12:1009-1059.
8. Bochkov V.N., Philippova M., Oskolkova O., Kadl A., Furnkranz A., Karabeg E., Afonyushkin T., Gruber F., Breuss J., Minchenko A., Mechtcheriakova D., Hohensinner P., Rychli K., Wojta J., Resink T., Erne P., Binder B.R., Leitinger N. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ. Res. 2006, 99:900-908.
9. Broekhuyse R.M. Phospholipids in tissues of the eye. I. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids. Biochem. Biophys. Acta 1968, 152:307-315.
10. de Jong P.T. Age-related macular degeneration. N.Engl. J. Med. 2006, 355:1474-1485.
11. Funk M., Karl D., Georgopoulos M., Benesch T., Sacu S., Polak K., Zlabinger G.J., Schmidt-Erfurth U. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 2009, 116:2393-2399.
12. Gargalovic P.S., Gharavi N.M., Clark M.J., Pagnon J., Yang W.P., He A., Truong A., Baruch-Oren T., Berliner J.A., Kirchgessner T.G., Lusis A.J. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2490-2496.
13. Gruber F., Oskolkova O., Leitner A., Mildner M., Mlitz V., Lengauer B., Kadl A., Mrass P., Kronke G., Binder B.R., Bochkov V.N., Leitinger N., Tschachler E. Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells. J.Biol. Chem. 2007, 282:16934-16941.
14. Kliffen M., Sharma H.S., Mooy C.M., Kerkvliet S., de Jong P.T. Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol. 1997, 81:154-162.
15. Kramerov A.A., Saghizadeh M., Pan H., Kabosova A., Montenarh M., Ahmed K., Penn J.S., Chan C.K., Hinton D.R., Grant M.B., Ljubimov A.V. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am. J. Pathol. 2006, 168:1722-1736.
16. Ljubimov A.V., Caballero S., Aoki A.M., Pinna L.A., Grant M.B., Castellon R. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 2004, 45:4583-4591.
17. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 1996, 37:855-868.
18. Maminishkis A., Chen S., Jalickee S., Banzon T., Shi G., Wang F.E., Ehalt T., Hammer J.A., Miller S.S. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthalmol. Vis. Sci. 2006, 47:3612-3624.
19. Martin D.F., Maguire M.G., Fine S.L., Ying G.S., Jaffe G.J., Grunwald J.E., Toth C., Redford M., Ferris F.L. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012, 119:1388-1398.
20. Mitchell P. Asystematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab. Curr. Med. Res. Opin. 2011, 27:1465-1475.
21. Niture S.K., Jaiswal A.K. Hsp90 interaction with INrf2(Keap1) mediates stress-induced Nrf2 activation. J.Biol. Chem. 2010, 19:36865-36875.
22. Oskolkova O.V., Afonyushkin T., Leitner A., von Schlieffen E., Gargalovic P.S., Lusis A.J., Binder B.R., Bochkov V.N. ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Blood 2008, 112:330-339.
23. Pollreisz A., Funk M., Breitwieser F.P., Parapatics K., Sacu S., Georgopoulos M., Dunavoelgyi R., Zlabinger G.J., Colinge J., Bennett K.L., Schmidt-Erfurth U. Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes. Exp. Eye Res. 2013, 108:48-58.
24. Poole A., Poore T., Bandhakavi S., McCann R.O., Hanna D.E., Glover C.V. Aglobal view of CK2 function and regulation. Mol. Cell. Biochem. 2005, 274:163-170.
25. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y. Ranibizumab for neovascular age-related macular degeneration. N.Engl. J. Med. 2006, 355:1419-1431.
26. Roybal C.N., Hunsaker L.A., Barbash O., Vander Jagt D.L., Abcouwer S.F. The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J.Biol. Chem. 2005, 280:20331-20339.
27. Roybal C.N., Yang S., Sun C.W., Hurtado D., Vander Jagt D.L., Townes T.M., Abcouwer S.F. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J.Biol. Chem. 2004, 279:14844-14852.
28. Suzuki M., Kamei M., Itabe H., Yoneda K., Bando H., Kume N., Tano Y. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol. Vis. 2007, 13:772-778.
29. Suzuki M., Tsujikawa M., Itabe H., Du Z.J., Xie P., Matsumura N., Fu X., Zhang R., Sonoda K.H., Egashira K., Hazen S.L., Kamei M. Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J.Cell Sci. 2012, 125:2407-2415.
30. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence invivo. J.Biol. Chem. 1997, 272:13597-13607.
31. Witmer A.N., Vrensen G.F., Van Noorden C.J., Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye. Res. 2003, 22:1-29.
32. Yoshimura T., Sonoda K.H., Sugahara M., Mochizuki Y., Enaida H., Oshima Y., Ueno A., Hata Y., Yoshida H., Ishibashi T. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009, 4:e8158.